<p>卡博特（NYSE:CBT - 獲取免費報告）在週五發佈給投資者的研究報告中，摩根大通的股票分析師將其目標價格從 105.00 美元下調至 85.00 美元。該公司目前對這家特種化學公司的股票給予 “減持” 評級。摩根大通的目標價格表明，相較於該公司之前的收盤價，存在 1.01% 的潛在下行空間。</p>
<ul>
<li>現在購買的 10 只最佳天然氣股票</li>
</ul>
<p>其他幾位股票研究分析師也最近對該公司發表了評論。StockNews.com 在週二的研究報告中將卡博特的評級從 “持有” 上調至 “買入”。瑞穗證券在 1 月 7 日的研究報告中將卡博特的目標價格從 122.00 美元下調至 110.00 美元，並給予該公司 “跑贏大盤” 的評級。已有一位研究分析師對該股票給予賣出評級，兩位給予持有評級，兩位給予買入評級。根據 MarketBeat.com 的數據，卡博特目前的共識評級為 “持有”，平均目標價格為 97.00 美元。</p>
<p><strong>查看我們對卡博特的最新分析</strong></p>
<h2>卡博特股票上漲 0.4%</h2>
<ul>
<li>卡博特在電動車市場提升鋰電池鏈的生產</li>
</ul>
<p>週五，NYSE:CBT 的股票在交易中上漲 0.36 美元，達到 85.87 美元。該公司交易了 58,573 股，而其平均交易量為 389,003 股。該公司的 50 日簡單移動平均為 89.85 美元，200 日簡單移動平均為 101.05 美元。該公司的速動比率為 1.29，流動比率為 2.00，債務與股本比率為 0.72。卡博特的 1 年最低價為 81.24 美元，1 年最高價為 117.46 美元。該公司的市值為 46.6 億美元，市盈率為 11.41，市盈增長比率為 0.77，貝塔值為 1.19。</p>
<p>卡博特（NYSE:CBT - 獲取免費報告）最近一次發佈季度財報是在 2 月 3 日，特種化學公司報告每股收益（EPS）為 1.76 美元，超出分析師的共識預期 1.74 美元 0.02 美元。卡博特的股本回報率為 26.79%，淨利潤率為 10.60%。分析師預計卡博特在當前財政年度的每股收益將達到 7.57 美元。</p>
<p>卡博特宣佈其董事會於 12 月 3 日啓動了一項股票回購計劃，允許公司回購 1,000 萬股流通股。這項回購授權允許這家特種化學公司通過公開市場購買其股票。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
<h2>機構資金流入和流出</h2>
<p>幾家機構投資者最近買入和賣出了該公司的股票。R Squared Ltd 在第四季度購買了卡博特的新頭寸，價值約 26,000 美元。Farther Finance Advisors LLC 在第三季度將其在卡博特的持股增加了 197.9%。Farther Finance Advisors LLC 現在擁有 417 股這家特種化學公司的股票，價值 47,000 美元，此前在上個季度又購買了 277 股。CWM LLC 在第三季度將其在卡博特的持股增加了 35.6%。CWM LLC 現在擁有 564 股這家特種化學公司的股票，價值 63,000 美元，此前在該期間又收購了 148 股。First Horizon Advisors Inc.在第三季度將其在卡博特的持股增加了 22.0%。First Horizon Advisors Inc.現在擁有 650 股這家特種化學公司的股票，價值 73,000 美元，此前在上個季度又收購了 117 股。最後，EverSource Wealth Advisors LLC 在第四季度將其在卡博特的持股增加了 37.2%。EverSource Wealth Advisors LLC 現在擁有 808 股這家特種化學公司的股票，價值 74,000 美元，此前在該期間又收購了 219 股。機構投資者持有該公司 93.18% 的股票。</p>
<h2>卡博特公司簡介</h2>
<p>（獲取免費報告）</p>
<p>卡博特公司作為一家特種化學和性能材料公司運營。該公司通過兩個部門運營，分別是增強材料和性能化學品。它提供用於輪胎的增強碳，作為橡膠增強劑和性能添加劑，以及用於工業產品，如軟管、皮帶、擠出型材和模製品；以及工程彈性體複合材料解決方案。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票超過卡博特</li>
<li>市值計算器：如何計算市值</li>
<li>隨着 “壯麗七俠” 的停滯，這三隻股票正在獲得動力</li>
<li>如何使用 MarketBeat Excel 股息計算器</li>
<li>黃金的上升：礦商和 ETF 能否將投資者帶到 3000 美元？</li>
<li>股票情緒分析：它是如何工作的</li>
<li>美敦力的擴張獲得動力——市場轉變的時機到了嗎？</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在卡博特嗎？</h2>
<p>在你考慮卡博特之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而卡博特並不在名單上。</p>
<p>雖然卡博特目前在分析師中獲得 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

卡博特

<p>摩根大通已將卡博特（NYSE:CBT）的目標股價從 105.00 美元下調至 85.00 美元，並給予 “減持” 評級。這表明與前一交易日收盤價相比，存在 1.01% 的潛在下行空間。其他分析師的評級則各有不同，其中一位為賣出，兩個為持有，兩個為買入。卡博特目前的平均目標價格為 97.00 美元。該股票交易價格為 85.87 美元，市值為 46.6 億美元，市盈率為 11.41。公司最近啓動了一項 1000 萬股的股票回購計劃，表明管理層對公司被低估的信心</p>

<p>Cabot (NYSE:CBT - Get Free Report) had its price target dropped by stock analysts at JPMorgan Chase &amp; Co. from $105.00 to $85.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has an &#34;underweight&#34; rating on the specialty chemicals company's stock. JPMorgan Chase &amp; Co.'s price target indicates a potential downside of 1.01% from the company's previous close.</p>
<div class="lb-trans"><p>卡博特（NYSE:CBT - 獲取免費報告）在週五發佈給投資者的研究報告中，摩根大通的股票分析師將其目標價格從 105.00 美元下調至 85.00 美元。該公司目前對這家特種化學公司的股票給予 “減持” 評級。摩根大通的目標價格表明，相較於該公司之前的收盤價，存在 1.01% 的潛在下行空間。</p>
</div><ul>
<li>10 Best Natural Gas Stocks to Buy Now</li>
</ul>
<div class="lb-trans"><ul>
<li>現在購買的 10 只最佳天然氣股票</li>
</ul>
</div><p>Several other equities research analysts have also recently commented on the company. StockNews.com raised Cabot from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Tuesday. Mizuho decreased their target price on shares of Cabot from $122.00 to $110.00 and set an &#34;outperform&#34; rating for the company in a research report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Cabot presently has a consensus rating of &#34;Hold&#34; and an average target price of $97.00.</p>
<div class="lb-trans"><p>其他幾位股票研究分析師也最近對該公司發表了評論。StockNews.com 在週二的研究報告中將卡博特的評級從 “持有” 上調至 “買入”。瑞穗證券在 1 月 7 日的研究報告中將卡博特的目標價格從 122.00 美元下調至 110.00 美元，並給予該公司 “跑贏大盤” 的評級。已有一位研究分析師對該股票給予賣出評級，兩位給予持有評級，兩位給予買入評級。根據 MarketBeat.com 的數據，卡博特目前的共識評級為 “持有”，平均目標價格為 97.00 美元。</p>
</div><p><strong>View Our Latest Analysis on Cabot</strong></p>
<div class="lb-trans"><p><strong>查看我們對卡博特的最新分析</strong></p>
</div><h2>Cabot Stock Up 0.4 %</h2>
<div class="lb-trans"><h2>卡博特股票上漲 0.4%</h2>
</div><ul>
<li>Cabot Boosting Production In Lithium Battery Chain For EV Market</li>
</ul>
<div class="lb-trans"><ul>
<li>卡博特在電動車市場提升鋰電池鏈的生產</li>
</ul>
</div><p>Shares of NYSE:CBT traded up $0.36 during trading on Friday, reaching $85.87. 58,573 shares of the company traded hands, compared to its average volume of 389,003. The firm has a fifty day simple moving average of $89.85 and a 200 day simple moving average of $101.05. The company has a quick ratio of 1.29, a current ratio of 2.00 and a debt-to-equity ratio of 0.72. Cabot has a 1-year low of $81.24 and a 1-year high of $117.46. The firm has a market cap of $4.66 billion, a P/E ratio of 11.41, a price-to-earnings-growth ratio of 0.77 and a beta of 1.19.</p>
<div class="lb-trans"><p>週五，NYSE:CBT 的股票在交易中上漲 0.36 美元，達到 85.87 美元。該公司交易了 58,573 股，而其平均交易量為 389,003 股。該公司的 50 日簡單移動平均為 89.85 美元，200 日簡單移動平均為 101.05 美元。該公司的速動比率為 1.29，流動比率為 2.00，債務與股本比率為 0.72。卡博特的 1 年最低價為 81.24 美元，1 年最高價為 117.46 美元。該公司的市值為 46.6 億美元，市盈率為 11.41，市盈增長比率為 0.77，貝塔值為 1.19。</p>
</div><p>Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. Analysts anticipate that Cabot will post 7.57 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>卡博特（NYSE:CBT - 獲取免費報告）最近一次發佈季度財報是在 2 月 3 日，特種化學公司報告每股收益（EPS）為 1.76 美元，超出分析師的共識預期 1.74 美元 0.02 美元。卡博特的股本回報率為 26.79%，淨利潤率為 10.60%。分析師預計卡博特在當前財政年度的每股收益將達到 7.57 美元。</p>
</div><p>Cabot declared that its board has initiated a share repurchase plan on Tuesday, December 3rd that permits the company to repurchase 10,000,000 outstanding shares. This repurchase authorization permits the specialty chemicals company to repurchase shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's management believes its stock is undervalued.</p>
<div class="lb-trans"><p>卡博特宣佈其董事會於 12 月 3 日啓動了一項股票回購計劃，允許公司回購 1,000 萬股流通股。這項回購授權允許這家特種化學公司通過公開市場購買其股票。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>Several institutional investors have recently bought and sold shares of the company. R Squared Ltd bought a new position in shares of Cabot in the fourth quarter worth about $26,000. Farther Finance Advisors LLC lifted its holdings in shares of Cabot by 197.9% during the third quarter. Farther Finance Advisors LLC now owns 417 shares of the specialty chemicals company's stock worth $47,000 after buying an additional 277 shares during the last quarter. CWM LLC boosted its position in shares of Cabot by 35.6% in the third quarter. CWM LLC now owns 564 shares of the specialty chemicals company's stock valued at $63,000 after acquiring an additional 148 shares during the period. First Horizon Advisors Inc. grew its stake in shares of Cabot by 22.0% in the third quarter. First Horizon Advisors Inc. now owns 650 shares of the specialty chemicals company's stock worth $73,000 after acquiring an additional 117 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its position in Cabot by 37.2% during the fourth quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock worth $74,000 after acquiring an additional 219 shares during the period. Institutional investors own 93.18% of the company's stock.</p>
<div class="lb-trans"><p>幾家機構投資者最近買入和賣出了該公司的股票。R Squared Ltd 在第四季度購買了卡博特的新頭寸，價值約 26,000 美元。Farther Finance Advisors LLC 在第三季度將其在卡博特的持股增加了 197.9%。Farther Finance Advisors LLC 現在擁有 417 股這家特種化學公司的股票，價值 47,000 美元，此前在上個季度又購買了 277 股。CWM LLC 在第三季度將其在卡博特的持股增加了 35.6%。CWM LLC 現在擁有 564 股這家特種化學公司的股票，價值 63,000 美元，此前在該期間又收購了 148 股。First Horizon Advisors Inc.在第三季度將其在卡博特的持股增加了 22.0%。First Horizon Advisors Inc.現在擁有 650 股這家特種化學公司的股票，價值 73,000 美元，此前在上個季度又收購了 117 股。最後，EverSource Wealth Advisors LLC 在第四季度將其在卡博特的持股增加了 37.2%。EverSource Wealth Advisors LLC 現在擁有 808 股這家特種化學公司的股票，價值 74,000 美元，此前在該期間又收購了 219 股。機構投資者持有該公司 93.18% 的股票。</p>
</div><h2>Cabot Company Profile</h2>
<div class="lb-trans"><h2>卡博特公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.</p>
<div class="lb-trans"><p>卡博特公司作為一家特種化學和性能材料公司運營。該公司通過兩個部門運營，分別是增強材料和性能化學品。它提供用於輪胎的增強碳，作為橡膠增強劑和性能添加劑，以及用於工業產品，如軟管、皮帶、擠出型材和模製品；以及工程彈性體複合材料解決方案。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Cabot</li>
<li>Market Cap Calculator: How to Calculate Market Cap</li>
<li>As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum</li>
<li>How to Use the MarketBeat Excel Dividend Calculator</li>
<li>Gold's Ascent: Can Miners and ETFs Take Investors to $3,000?</li>
<li>Stock Sentiment Analysis: How it Works</li>
<li>Medtronic’s Expansion Gains Momentum—Time for a Market Shift?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過卡博特</li>
<li>市值計算器：如何計算市值</li>
<li>隨着 “壯麗七俠” 的停滯，這三隻股票正在獲得動力</li>
<li>如何使用 MarketBeat Excel 股息計算器</li>
<li>黃金的上升：礦商和 ETF 能否將投資者帶到 3000 美元？</li>
<li>股票情緒分析：它是如何工作的</li>
<li>美敦力的擴張獲得動力——市場轉變的時機到了嗎？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cabot Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在卡博特嗎？</h2>
</div><p>Before you consider Cabot, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮卡博特之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而卡博特並不在名單上。</p>
</div><p>While Cabot currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然卡博特目前在分析師中獲得 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

摩根大通降低了對卡博特（NYSE:CBT）股票價格的預期